Methadone but not morphine inhibits lubiprostone-stimulated Cl- currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl- currents.
about
Opioid-induced constipation: advances and clinical guidanceEvolving paradigms in the treatment of opioid-induced bowel dysfunctionEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetThe role of naloxegol in the management of opioid-induced bowel dysfunctionChronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunitiesNovel therapeutic agents in neurogastroenterology: advances in the past year.Lubiprostone in constipation: clinical evidence and place in therapy.Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipationA randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosaGenetic Ablation of the ClC-2 Cl- Channel Disrupts Mouse Gastric Parietal Cell Acid Secretion.Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.New Options in Constipation Management.Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.Opioid-Related Constipation in Patients With Non-cancer Pain Syndromes: a Review of Evidence-Based Therapies and Justification for a Change in Nomenclature.Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.Opioids and GI Motility-Friend or Foe?Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.Long-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain.Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.The Evolving Role of Long-Term Pharmacotherapy for Opioid-Induced Constipation in Patients Being Treated for Noncancer Pain.New developments in the treatment of opioid-induced gastrointestinal symptomsUnderstanding the Agent, Part II: Adverse EffectsOral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone
P2860
Q26765571-109F2E6E-FCD8-4EF0-AC57-B1343EB204A8Q26777692-9E60C394-A5BF-41E4-97C4-770F831881ACQ27010907-A46EB525-7EE4-48E5-9140-EFC3D70F7432Q28066092-16EE0362-A507-4DEE-8123-5B03121EF6F4Q28072039-833E86CD-EBB4-49FD-B091-8379508AF8E2Q28083547-199BF5EA-4766-4F7E-BA2A-44F8CBA14777Q33934623-D7A00166-74D5-418F-8084-CB9CC31056FCQ35091370-28360A4F-FB7B-4F6D-9BCF-A76BA49B106FQ35174654-1145F4F7-71C9-42B6-A510-C7751A8A6F0CQ35583262-B777A7FB-4A3C-46D5-B2A0-2029F95CD03CQ35664952-74AF49E4-B16A-453D-BD1F-6D309E51376BQ35778280-3ABABA0D-D345-4D8A-9177-2AFAF2C3B1EBQ37200907-2893A69C-B265-424D-ADD5-4896AAFD3C17Q38602701-BA86096E-546C-44CB-9B7C-8D52B48C0710Q38761898-22E3B27E-47E0-40AE-ACF4-CD16EC724B80Q38772298-E834D574-1820-463C-9595-FB8C3AC8B75BQ38880480-CB6C75DF-08CC-4E21-8ECC-85DAA63A6404Q38976799-29E62D54-37FF-465E-93CE-731C1663E6EAQ38997203-1755DF65-3AD4-4F95-A027-B9B6AB60CF06Q39175158-5D9B0EDD-0C93-4ADF-9016-385501580F44Q44331744-B7CDA29C-CEF2-4A17-97BC-3A5593A44266Q44349621-E0059BE2-EFBD-49B7-8C6C-470B45D3DC3AQ50062006-3534FD25-E15F-4CF0-AF76-96A6CB9269EAQ57063309-B80192A0-5976-476D-A5D9-48CC57E4E0A7Q57462906-2B98088F-9A79-4D54-B389-BC6E33224602Q58694488-62411C78-A867-49AA-B871-2DE734838F59
P2860
Methadone but not morphine inhibits lubiprostone-stimulated Cl- currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl- currents.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Methadone but not morphine inh ...... -2, but not CFTR Cl- currents.
@en
Methadone but not morphine inh ...... -2, but not CFTR Cl- currents.
@nl
type
label
Methadone but not morphine inh ...... -2, but not CFTR Cl- currents.
@en
Methadone but not morphine inh ...... -2, but not CFTR Cl- currents.
@nl
prefLabel
Methadone but not morphine inh ...... -2, but not CFTR Cl- currents.
@en
Methadone but not morphine inh ...... -2, but not CFTR Cl- currents.
@nl
P2093
P2860
P1476
Methadone but not morphine inh ...... C-2, but not CFTR Cl- currents
@en
P2093
Danuta H Malinowska
John Cuppoletti
Kirti Tewari
P2860
P2888
P356
10.1007/S12013-012-9406-6
P577
2013-05-01T00:00:00Z